Herbert Yu

Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer

R. Narayan, C. Guha, K. Shetty, 2022, Genes & cancer.

Pathogenesis to management of hepatocellular carcinoma

J. M. Crawford, J. Crawford, P. Shah, 2022, Genes & cancer.

β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development

P. Pajukanta, M. Allison, M. Vacca, 2021, Science Translational Medicine.

Focal Point of Fanconi Anemia Signaling

Youping Deng, T. Bezabeh, P. Fei, 2021, International journal of molecular sciences.

Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case–control study

S. Mayne, M. Irwin, H. Risch, 2020, Cancer Causes & Control.

Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis

A. Krainer, N. Chambwe, K. Ohshiro, 2024, Genes & cancer.

Genetic susceptibility to hepatocellular carcinoma in Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association chromosome 22q13.31, findings of a genome-wide association study. study.

Y. Kamatani, C. Tanikawa, Jian-Min Yuan, 2022 .